Written by a model from the transcript; not yet reviewed.
This episode explores the career, medical philosophies, and controversies surrounding longevity doctor Peter Attia. The guest and host examine how Attia transitioned from leaving a medical residency to working at McKinsey and Company during their involvement with Purdue Pharma, and later building an exclusive, high-priced concierge medical practice. They analyze his Med 3.0 framework, his promotion of aggressive monitoring and off-label pharmaceuticals like rapamycin, and how his science-washing approach aligns with wellness influencers and anti-vaccine figures. Finally, the discussion dives into newly released Epstein files showing Attia's extensive correspondence and relationship with Jeffrey Epstein.
The hosts discuss Attia’s departure from medical training and his reputation as a medical rebel.
The conversation shifts to Attia’s time at McKinsey and the firm’s role in fueling the opioid epidemic.
The hosts analyze Attia’s promotion of rapamycin and other off‑label drugs for longevity.
The hosts critique Attia’s aggressive testing and treatment protocols, questioning their evidence base.
The episode examines Attia’s stance on preventive care versus overdiagnosis and the ethics of end-of-life discussions.
Hosts open the episode and play a brief advertising spot before diving into the main discussion.
The hosts analyze Attia’s media presence, his influence on the manosphere, and his approach to medical science.
Discussion of Attia’s criticism of current medical progress and his vision for a future where longevity is prioritized.
The hosts reveal how Attia’s correspondence with Jeffrey Epstein shows a troubling relationship that led to his CBS fallout.
The conversation reflects on how doctors can be lured by wealth and fame, risking patient care and public trust.
McKinsey and Purdue Pharmastory
The hosts discuss McKinsey and Company's consulting work for Purdue Pharma, advising them to aggressively increase OxyContin sales and target high-volume prescribers.
Peter Attia's private longevity clinic, Early Medicine, charges elite clients anywhere from one hundred to five hundred thousand dollars annually.
Patient Satisfaction Studydata
A 2012 UC Davis study revealed that the most satisfied patients had higher healthcare spending and a 26 percent higher risk of death.
Rapamycin, a longevity medication prescribed off-label by Attia, was originally discovered as an antifungal compound in soil from Easter Island.
Recently released DOJ files revealed over 1,700 mentions of Peter Attia and embarrassing emails showing his relationship with Jeffrey Epstein.
Family Crisis and Prioritiesstory
While Attia's one-month-old son was in the ICU after nearly dying, Attia chose to stay in New York to pursue work and meet with Jeffrey Epstein.
“The DOJ leveled a criminal misbranding charge against McKinsey for falsely marketing it as less addictive, less subject to abuse and diversion, and less likely to cause dependence and withdrawal than other pain medications.”
“You should get colon cancer screening, but colonoscopy does have some risk and it's not cheap.”
“There's some increased risk to infection, as I mentioned, the development of lymphoma, and some metabolic problems that the whole field of longevity is really supposedly aimed to prevent.”
“He knows how to talk about data in a way that's even more convincing, I feel, than Andrew Huberman.”
“To be clear, I never witnessed illegal behavior and never saw anyone who appeared underage in his presence.”
In Part Two, Robert is again joined by Dr. Kaveh Hoda to discuss the rise and fall of the doctor at the center of the wellness podcast circuit: Dr. Peter Attia. From his stent as a McKinsey consult consultant to his pricey concierge longevity practice, a hit podcast, and a #1 bestseller. We break down "Medicine 3.0" and where the evidence holds up, where it doesn't, and how a smart, credible doctor can end up giving cover to the MAHA crowd. Finally, we get into his emails with Jeffrey Epstein, the fallout at CBS and his sponsors, and what it all says about doctors, fame, and wealthy patients. Content note: discusses Jeffrey Epstein and sexual abuse. Sources: Attia, Peter. Outlive: The Science and Art of Longevity. March 28, 2023. Johansson, Minna, et al. "Continuous Glucose Monitoring for Persons With and Without Diabetes." JAMA, August 3, 2026. Khullar, Dhruv. "How to Die in Good Health." The New Yorker, April 15, 2024. Mann, Brian. "McKinsey & Company to Pay $650 Million for Role in Opioid Crisis." NPR, December 13, 2024. Martin, Kristen. "The Problem With Peter Attia: The Longevity Guru Turned Up in the Epstein Files. Should We Have Taken His Health Advice So Seriously in the First Place?" Slate, February 26, 2026. Ruetenik, Daniel, and Arden, Farhi. "Dr. Peter Attia, Longevity Expert, Apologizes for 'Indefensible' Emails to Jeffrey Epstein." CBS News, February 2, 2026. Tyrangiel, Josh. "The Epstein Spectrum." The Atlantic, April 3, 2026. Walker, Graham. "A Skeptic's Review of Peter Attia's Outlive." LinkedIn, January 13, 2024. https://www.linkedin.com/pulse/skeptics-review-peter-attias-outlive-graham-walker-md-z6rsc Blum, Dani "Peter Attia's Ties to Epstein Spark Backlash From Doctors." The New York Times, February 10, 2026 Kaufman, Maya and Gardner, Laura . "I Think She Will Be Loyal: Jeffrey Epstein's Role in Peter Attia's Rise." Politico, March 16, 2026. Pollack, Neal. "The Plight of Peter Attia." The Spectator, July 15, 2025. Greene, Jenna. Epstein files up in lawsuit, over stock options by longevity expert, Peter Attia. March 20, 2026 Podcasts: The Peter Attia Drive. Episode 168, August 2021. The Peter Attia Drive. Episode 172, August 2021. The Peter Attia Drive. Episode 190, January 10, 2022. The Peter Attia Drive. Episode 298, April 15, 2024. The Joe Rogan Experience. Episode 1735, 1961 Jocko Podcast. Episodes 55, 56, and 392. The Tim Ferriss Show. Episode 398, "Peter Attia, MD: Fasting, Metformin, Athletic Performance, and More," November 27, 2019. See omnystudio.com/listener https://omnystudio.com/listener for privacy information.
15,537 words · 8 speakers
Speaker names marked are inferred from speaking time and the show’s known hosts — they are not voice-verified.
Page updated · transcript and summary are machine-generated